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The immune system in action is an impressive piece of choreography. Exquisite balance is 
essential, maintaining protection against a diverse array of pathogens while preventing immune-
mediated pathologies. Understanding the mechanisms behind such balance is a high priority for 
research and clinical communities. In the last decade, there has been growing interest in immune 
cell nutrition and metabolism, giving rise to the emerging field of “immunometabolism” and 
casting new light on the regulation of immune cell activity. Here we present an exciting new 
series of review articles that consider immunometabolism in the context of infection, discussing 
new insights in immune cell migration, function, and persistence, and new perspectives on how 
metabolites can mediate the fraught dialogue between invading pathogens and their host. 
 
The field of immunometabolism rests upon the foundation that immune cells show distinct states 
of nutrient and energy metabolism during activation compared to their inactivated state(1). 
Superficially, it may be no surprise that an activated cell consumes and uses energy differently 
than a cell at rest. Nevertheless, this simple premise has resulted in an explosion of inquiry into 
how nutrient usage and cellular energetics are regulated during an immune response, and how 
these processes direct downstream cellular function(2–4). The study of immunometabolism has 
been revolutionary in immunology, opening another “lens” through which to view the nuanced 
complexity of immune response regulation.  
 
Early studies in immunometabolism focused on the gross characterization of shifts in cellular 
metabolism that occur during immune cell activation(5–7). In most contexts, both myeloid and 
lymphoid cells upregulate their consumption of glucose to fuel their effector functions(8,9). 
However, immune cell activation is not a simple “on/off” metabolic switch, but rather a 
qualitative engagement and prioritisation of distinct metabolic pathways that can specifically 
support unique effector outcomes, such as polarization of T helper cells or specification of 
macrophage effector responses. This review series highlights recent advances in understanding 
the links between metabolism and function in immune cells, using the context of microbial 
infection to illuminate immunometabolism in action. The series illustrates the convergence of 
metabolism with other forms of cellular regulation, including epigenetics, post-translational 
modifications, and nutrient competition. The reviews emphasize the role of immunometabolism 
in the beauty of the immune orchestration required to eradicate pathogens and yet maintain 
balance throughout the immune responses to infection. 
 
We are publishing the review series in two parts. The first half of this series, presented here, 
focuses on metabolic mechanisms and discusses their influence on immune cell activity and 
protection from infection. Topics in this part of the series include the influence of cellular 
metabolism on epigenetic regulation, post-translational protein modification, immune cell 
trafficking, and intestinal homeostasis. The second half of the series which will be published in 
early 2021, provides specific examples of immunometabolism in action in particular infections, 
illustrating its ability to mediate the conversations between host and pathogen and to influence 
disease outcome. 
 
In the first article of this series, Lio and Huang address emerging evidence of the connection 
between metabolic processes and epigenetic regulation of gene expression(10). The authors 
introduce one-carbon metabolism and highlight the key metabolites S-adenosylmethionine 
(SAM) and α-ketoglutarate (αKG) as important contributors to the DNA methylation cycle in 
both innate and adaptive immune cells. They discuss the critical role of the TCA cycle 
intermediate αKG as a cofactor for a family of dioxygenase enzymes which play fundamental 
roles in the epigenetic regulation of inflammation-associated genes(11). These dioxygenases 
include the ten-eleven translocation (TET) methylcytosine oxidases which are required for 
proper lymphocyte development and activation, neatly illustrating the importance of metabolic 
regulation of gene expression.  
 
TET methylcytosine oxidases are also iron-dependent(11,12), and Geros and colleagues discuss 
the central importance of iron as a metabolic regulator of both host and pathogen. Iron is 
essential to every living cell, being a required cofactor for enzymes involved in DNA synthesis 
and mitochondrial function. Tight regulation of iron availability is a key immune defense against 
bacterial pathogens, and the human gut is a dynamic frontline of a battle for access to iron. Host 
defense mechanisms that capture iron and prevent accessibility to microbes affect the intestinal 
microbiota as well as unwanted pathogens, and Geros et al highlight the metabolic dialogues 
between host, pathogen and commensal that determine health and dysbiosis. The authors also 
provide valuable perspectives on the therapeutic potential of targeting iron metabolism and iron 
availability, considering the impact on both host and pathogen. 
 
Building on the conversation between host and pathogen, Quik, Hokke and Everts introduce us 
to a novel mechanism of metabolic control over immune defenses (13). They describe an 
emerging connection between the hexosamine biosynthesis pathway (HBP) and a specific form 
of post-translational glycosylation termed O-GlcNAcylation. O-GlcNAcylation can alter 
functional properties of the proteins that it modifies(14,15) and the pathway particularly targets 
transcription factors and epigenetic regulators. This review dovetails beautifully with the work 
presented by Lio and Huang, both describing the multi-faceted ways in which cellular 
metabolism can influence genetic regulation. Quik and colleagues comprehensively address the 
existing evidence for HBP-mediated O-GlcNAcylation in regulating immune cell function in 
responses to bacterial, viral, fungal, and parasitic infections, providing exciting new insight into 
metabolic control across the broad diversity of antimicrobial responses. Their work highlights 
the therapeutic promise of targeting HBP metabolism and O-GlcNAcylation as a mechanism of 
host-protective immunological intervention. 
 
Our final mechanistic article is a thought-provoking piece by Guak and Krawczyk, in which the 
authors consider how shifts in nutrient usage and energy production support the motility and 
location of both innate and adaptive immune cells (16). One of the highlights of this article is in 
its discussion of the exciting finding that metabolic enzyme activity and energy production can 
be geospatially compartmentalized within the cell to support the unique energetic demands of 
directional chemotaxis(17). This pertains not only to the compartmentalization of glycolytic 
enzyme machinery in the cytoplasm, but also to specific regional location of mitochondria in 
areas of the cell that support high-energy demands, such as the leading edge of a migrating cell. 
Guak and Krawczyk discuss nuanced metabolic contexts such as hypoxia and dyslipidemia, and 
describe the impact of these pathophysiological states on cellular metabolism and consequently 
cell motility. Such metabolic restrictions are decisive components of pathological 
microenvironments and understanding their significance is an essential step towards therapeutic 
intervention in disease states associated with altered nutrient microenvironments, including 
infection and cancer. 
 
Together our four groups of authors presented here provide a fantastic discussion of the 
metabolic pressures and potential in the dynamic interaction between the mammalian host and 
diverse microbial pathogens. We hope you enjoy this collection of articles, and we also look 
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